publicaciones seleccionadas
-
documento
- HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab 2022-12
- HSD23 Operational Waste Savings on Health in a Value-Based Patient Drug Safety Program 2022-12
- HSD69 Cost Savings of Waste on Health by Pharmacological Inefficiencies in a Value-Based Patient Drug Safety Program 2022-12
- HSD92 Operational Savings Generated in an Integrated Care Clinic for Immune-Mediated Skin Disorders 2022-12